首页> 外文期刊>Drug delivery. >Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets.
【24h】

Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets.

机译:氢溴酸右美沙芬缓释片的配制和评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Sustained release (SR) matrix tablets of dextromethorphan hydrobromide were prepared by wet granulation using hydroxypropyl methyl cellulose (HPMC-K-100 CR) as the hydrophilic rate controlling polymer. The effect of the concentration of the polymer and different fillers on the in vitro drug release rate was studied. The studies indicated that the drug release can be modulated by varying the concentration of the polymer and the fillers. A complete cross-over bioavailability study of the optimized formulation of the developed sustained tablets and marketed immediate release tablets was performed on six healthy male volunteers. The extent of absorption of drug from the SR tablets was significantly higher than that for the marketed dextromethorphan hydrobromide tablet because of lower elimination rate and longer half-life.
机译:通过使用羟丙基甲基纤维素(HPMC-K-100 CR)作为亲水速率控制聚合物,通过湿法制粒制备氢溴酸右美沙芬的缓释(SR)基质片剂。研究了聚合物和不同填充剂的浓度对体外药物释放速率的影响。研究表明,可以通过改变聚合物和填充剂的浓度来调节药物的释放。对六名健康男性志愿者进行了开发的缓释片和市售速释片的优化配方的完整交叉生物利用度研究。由于较低的消除率和更长的半衰期,SR片剂对药物的吸收程度明显高于市售氢溴酸右美沙芬片。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号